info@seagull-health.com
SeagullHealth
语言:
search
new
Latest Price of Pemigatinib in 2025
502
Article source: Seagull Pharmacy
Sep 01, 2025

Pemazyre, with the English name pemigatinib, is a therapeutic drug for specific tumors. Its price, purchase channels, and storage methods have always been the focus of patients' attention. Pemazyre has been launched in China but has not yet been included in China's national medical insurance scheme, so patients need to purchase it at their own expense. The specification of pemigatinib is 13.5mg*14 tablets, and the price is 60 US dollars.

Latest Price of Pemigatinib in 2025

The price of pemigatinib is affected by many factors, including production costs, market demand, and medical insurance policies.

Price of the Original Research Drug

The original research pemigatinib is produced by well-known pharmaceutical enterprises, and its quality and efficacy have undergone strict verification. In 2025, the price of the original research pemigatinib may vary in different countries and regions, but the overall trend is to stabilize or decrease slightly. Patients can learn about the specific price by consulting local medical institutions or pharmacies.

Price of Generic Drugs

The Lucius (Laos) version of pemigatinib has a specification of 4.5mg*14 tablets, with a price of 60 US dollars per box. The above prices are for reference only.

How to Purchase Pemigatinib

When purchasing pemigatinib, patients should follow legal and safe channels.

Purchase from Hospital Pharmacies

Hospital pharmacies are one of the main channels for purchasing pemigatinib. With a prescription issued by a doctor, patients can buy regular and safe drugs from hospital pharmacies. The source of drugs in hospital pharmacies is traceable, the quality is guaranteed, and professional medication consultation and guidance are provided.

Purchase from Regular Pharmacies

In addition to hospital pharmacies, patients can also choose to buy pemigatinib from large chain pharmacies or community pharmacies with legal qualifications. When purchasing, patients should carefully check the drug packaging, labels, instructions, and other information. Patients can also consult pharmacists in the pharmacy to learn about the dosage, administration, and precautions of the drug.

How to Store Pemigatinib

Proper storage methods can help maintain the quality and efficacy of pemigatinib.

Storage Conditions

Pemigatinib should be stored in a dry, cool, and well-ventilated place, away from direct sunlight and high-temperature humid environments. Room temperature (20-25℃) is a suitable storage temperature. Patients should keep the drug out of the reach of children.

Moisture Prevention

Humid environments may cause the drug to deteriorate or become ineffective. When storing pemigatinib, patients should choose a dry and well-ventilated place to prevent the drug from getting damp. If the drug packaging is found to be damp or damaged, stop using it immediately and consult a doctor.

Regular Inspection

For the quality and efficacy of the drug, patients should regularly check the storage condition of pemigatinib, including checking whether the drug packaging is intact, whether the label is clear, and whether the expiration date has passed. If any problems or doubts are found, consult a doctor or pharmacist immediately.

Patients should purchase drugs through legal and safe channels and follow the correct storage methods to maintain the effectiveness of the medication.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
pemazyre(pemigatinib)
pemazyre(pemigatinib)
1. Cholangiocarcinoma 2. Myeloid/lymphoid neoplasms with FGFR1 rearrangement
WeChat Scan
Free Inquiry
Recommended Articles
Instructions for zotuximab (zolbetuximab)
Zolbetuximab has demonstrated significant therapeutic potential in the treatment of malignant tumors such as gastric cancer. Currently, zolbetuximab has not yet been launched in China. This article pr...
​Zolbetuximab: Indications, Dosage and Administration, and Precautions
Zolbetuximab has demonstrated significant therapeutic potential in the treatment of malignant tumors such as gastric cancer. Currently, zolbetuximab has not yet been launched in China. This article pr...
Precautions for Zolbetuximab
As an IgG1 monoclonal antibody targeting Claudin 18.2 (CLDN18.2), zolbetuximab plays a crucial role in the treatment of advanced or metastatic gastric cancer positive for CLDN18.2. The process of prep...
What is the Price of Zolbetuximab?
Zolbetuximab is a targeted therapeutic drug directed against CLDN18.2, and it has attracted significant attention in the field of gastric cancer treatment. It has been launched in China but is not inc...
How Much Does Pemigatinib Cost?
Pemigatinib is a therapeutic drug targeting specific types of cancer, indicated for the treatment of adult patients with metastatic or unresectable cholangiocarcinoma. It was launched in Mainland Chin...
What is the Price of Pemigatinib?
Pemigatinib is a targeted drug used for the targeted treatment of specific types of cancer. This article will explore in detail the price range of pemigatinib, its pharmacological mechanism of action,...
How to Buy Genuine Pemigatinib
Pemigatinib  has been launched in China but has not yet been included in China's national medical insurance system. Purchasing genuine pemigatinib is a crucial step in the treatment process f...
Formal Purchase Channels for Pemigatinib
Pemigatinib, developed by Incyte Corporation, was approved for marketing by the U.S. Food and Drug Administration (FDA) in April 2020 and launched in China in April 2022. It has not been included in C...
Related Articles
Dosage and Administration of Pemigatinib (Pemazyre) - Recommended Doses
Pemigatinib (Pemazyre) is a targeted therapy for specific genetic abnormalities, mainly indicated for the treatment of cholangiocarcinoma with FGFR2 genetic abnormalities and myeloid/lymphoid neoplasm...
Adverse Reactions of Pemigatinib (Pemazyre)
Pemigatinib (Pemazyre) is a targeted therapy indicated for the treatment of specific types of cholangiocarcinoma and myeloid/lymphoid neoplasms (MLN) with FGFR1 rearrangement.Adverse Reactions of Pemi...
What are the Precautions for Taking Pemigatinib (Pemazyre)?
Pemigatinib (Pemazyre) is an important targeted therapy for specific gene mutations, playing a pivotal role in the treatment of advanced cholangiocarcinoma and myeloid/lymphoid neoplasms (MLN) with FG...
What are the Indications for Pemigatinib (Pemazyre)?
Pemigatinib (Pemazyre) is an innovative kinase inhibitor. By specifically targeting the fibroblast growth factor receptor (FGFR) pathway, it provides a precision treatment option for patients with mal...
Where to Purchase Pemigatinib (Pemazyre)
Pemigatinib (Pemazyre) is a precision-targeted therapy for tumors with FGFR gene abnormalities. It has been approved for the treatment of previously treated, unresectable locally advanced or metastati...
What is Pemazyre (Pemigatinib)?
Pemazyre (pemigatinib) is a targeted therapy drug approved for marketing by the U.S. FDA in 2020. It belongs to the class of kinase inhibitors and is mainly used for the treatment of specific types of...
Precautions for the Use of Pemazyre (Pemigatinib)
Pemazyre (pemigatinib) is a kinase inhibitor that targets FGFR1/2/3. It inhibits tumor growth by blocking abnormal FGFR signaling pathways, but its use must strictly adhere to medication guidelines.Pr...
How to Use Pemazyre (Pemigatinib)
Pemazyre (pemigatinib) is a kinase inhibitor indicated for the treatment of adult patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma, and the presence of ...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved